Vol. 19 - Supplement
- ISSN 2183-1289
- The journal is indexed in Web of Science's SciELO Citation Index / Directory of Open Access Journals (DOAJ)
- Uncategorized - Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 5
- 1. In Memoriam – A tribute to Professor Jack W. Coburn
- Fernando Carrera
- Uncategorized - Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 7
- 2. Foreword: Why a new supplement on renal osteodystrophy?
- Fernando Carrera
- Uncategorized - Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 9-18
- 3. Renal osteodystrophy with special emphasis on secondary hyperparathyroidism.
- Ewa Lewin, Jinxing Huan, Klaus Olgaard
- Uncategorized - Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 19-29
- 4. Pathogenesis of secondary hyperparathyroidism and parathyroid hyperplasia.
- Eduardo Slatopolsky, Alex J. Brown, Adriana Dusso
- Uncategorized - Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 31-40
- 5. The different effects of high phosphate levels in chronic kidney disease.
- Antonio Canalejo, Yolanda Almadén, Mariano Rodríguez
- Uncategorized - Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 41-49
- 6. The impact of cardiovascular calcifications in chronic kidney disease: novel pathomechanistic insights.
- Markus Ketteler, Ralf Westenfeld, Vincent Brandenburg
- Uncategorized - Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 51-56
- 7. Vascular calcification, cardiovascular risk and arterial stiffness in haemodialysis patients.
- Teresa Adragão
- Uncategorized - Rev Port Nefrol Hipert 2005; 19 (4): 241-299
- 8. Serum markers of bone turnover in the diagnosis of renal osteodystrophy.
- Aníbal Ferreira
- Uncategorized - Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 73-80
- 9. Role of vitamin D metabolites in the regulation of PTH synthesis and secretion in chronic kidney disease.
- Justin Silver, Iddo Z. Ben Dov
- Uncategorized - Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 81-86
- 10. Vitamin D analogs for the management of secondary hyperparathyroidism.
- Kevin J. Martin, Esther A. González
- Uncategorized - Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 87-96
- 11. Paracalcitol therapy for secondary hyperparathyroidism.
- Myles Wolf, Ravi Thadhani
- Uncategorized - Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 97-108
- 12. Why target the parathyroid calcium-sensing receptor for the treatment of secondary hyperparathyroidism?
- Pablo Ureña Torres, Dominique Prié, Laurent Beck, Gérard Friedlander
- Uncategorized - Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 109-115
- 13. How are calcimimetics influencing our management of uraemic hyperparathyroidism?
- Simon J. Steddon, John Cunningham
- Uncategorized - Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 117-124
- 14. Sevelamer Hydrochloride: A new Approach to Hyperphosphatemia and Beneficial Effects Beyond Phosphate Control
- João M. Frazão, Patrícia Martins, Carla Santos-Araújo
- Uncategorized - Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 125-133
- 15. Lanthanum carbonate: a new potent non-calcaemic phosphate binder.
- Fouad Albaaj, Alastair J. Hutchison